As of December 2025 Inhibrx has a market cap of A$2.05 Billion. This makes Inhibrx the world's 5378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 7th, 2025 the market cap of Inhibrx was reported to be: